Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis

NCT03880266 is registered in ClinicalTrials.gov with Journey Medical Corporation as lead sponsor.

NCT NCT03880266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03880266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis
Lead sponsor
Journey Medical Corporation
Phase
Phase 2
Overall status
Completed
Start date
February 22, 2019
Completion date
May 24, 2019
Enrollment
72 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

palmar hyperhidrosis